ArticleClinical and experimental immunology2020

Rapamycin-based graft-versus-host disease prophylaxis increases the immunosuppressivity of myeloid-derived suppressor cells without affecting T cells and anti-tumor cytotoxicity.

J Scheurer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.